Contraception of women with intellectual disability: prevalence and determinants

Contraception of women with intellectual disability: prevalence and determinants
复制标题

DOI:
10.1046/j.1365-2788.2002.00360.x
复制
发表时间:
2002-02-01
影响因子:
3.6
通讯作者:
Roussaux, JP
Roussaux, JP
中科院分区:
医学3区
文献类型:
--
作者:
Servais, L;Jacques, D;Roussaux, JP

文献摘要

被引文献

相似文献

智障妇女的避孕是护理人员的一个主要关切。然而,避孕的普及率和使用不同方法(例如绝育)的频率仍然普遍未知。此外,针对ID妇女的适应症也存在争议。本文作者在布鲁塞尔和比利时瓦隆布拉班特省附近的97%的18至46岁的ID妇女中进行了一项基于人口的研究。在397名受试者中,40.8%未使用任何避孕方法,22.2%绝育,18.4%使用口服避孕药,17.6%使用醋酸甲羟孕酮,1%使用宫内节育器。这些数字与比利时总人口的数字相差很大。“避孕药具使用”的二元逻辑回归显示,睡眠环境(即机构或父母)、性关系政策和避孕政策等机构因素有很大影响。有或曾经有过一个男朋友也与更大的避孕概率相关。其他因素的影响较小(例如,ID水平较低)。很少有因素,其中没有一个是医疗的,与增加使用某种特定方法有关。目前的结果进行了讨论,根据一般的医疗应用的避孕和通常假设的具体指征的妇女ID。
The contraception of women with intellectual disability (ID) is a major concern for caregivers. However, the prevalence of contraception and the frequency of use of different methods (e.g. sterilization) remain generally unknown. Moreover, indications specific to women with ID are controversial. The present authors conducted a population-based study among 97% of the women with ID aged between 18 and 46 years attending government-funded facilities in Brussels and the nearby province of Walloon Brabant in Belgium. Out of 397 subjects, 40.8% did not use any contraceptive method, 22.2% were sterilized, 18.4% used an oral contraceptive agent, 17.6% used depot-medroxyprogesterone acetate and 1% used an intrauterine device. These figures differ widely from those of the general Belgian population. Binary logistic regression for `contraceptive utilization' showed the strong influence of institutional factors such as sleeping environment (i.e. institutional or parental), sexual relationship policy and contraception policy. Having or having had a boyfriend is also correlated with a stronger probability of contraceptive use. Other factors have a smaller influence (e.g. a milder level of ID). Very few factors, none of which are medical, are correlated with an increased use of a specific method. The present results are discussed in the light of the general medical application of contraception and the commonly assumed specific indications for women with ID.